review Open AccessTop 1% cited
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
Vaccine · 2012 · Vol. 30(12) · pp. 2212–2219
Jördis J. Ott(World Health Organization)Gretchen A Stevens(World Health Organization)Justina Groeger(Centers for Disease Control and Prevention)Steven Wiersma✉(World Health Organization)
Abstract
Declines in HBV infection prevalence may be related to expanded immunization. The increasing overall number of individuals being chronically infected with HBV, and the widespread global differences in HBV prevalence call for targeted approaches to tackle HBV-related mortality and morbidity. HBV infection prevalence data are needed at country and sub-national level to estimate disease burden and guide health and vaccine policy.
Hepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and TreatmentSeroprevalenceHBsAgHepatitis B virusEpidemiologyDemographyMedicineHepatitis BImmunologyVirusSerology
MeSH terms
AdolescentAdultAge FactorsAgedAged, 80 and overChildChild, PreschoolFemaleGeographyHepatitis B Surface AntigensHumansInfantInfant, NewbornMaleMiddle Aged
Funding
- Bill and Melinda Gates Foundation
- World Health Organization
Citations
1,840
FWCI
78.88
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
Cited by
AASLD guidelines for treatment of chronic hepatitis B
Hepatology · 2015 · 1,996 citations
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Journal of Hepatology · 2017 · 5,359 citations
References
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
International Journal of Cancer · 2010 · 21,378 citations
Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier State
The Journal of Infectious Diseases · 1985 · 834 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.